ArticleTranslational pediatrics2026
Endoplasmic reticulum stress-mediated disruption of mitochondrial homeostasis drives airway epithelial barrier fragility and enhances susceptibility to recurrent respiratory tract infections in children.
Article in Translational pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Recurrent respiratory tract infections (RRTIs) are among the most common pediatric health problems and impose substantial healthcare burden. Airway epithelial fragility is increasingly recognized as an important contributor to RRTIs in children, although the upstream molecular mechanisms remain incompletely understood. Endoplasmic reticulum (ER) stress and mitochondrial dysfunction have been implicated in epithelial injury in chronic airway diseases, yet their interplay in pediatric RRTIs is unclear. This study aimed to investigate whether ER stress-mediated disruption of mitochondrial homeostasis drives airway epithelial barrier fragility and enhances inflammatory susceptibility in children with RRTIs. Methods: Nasal swab samples from healthy children and RRTI patients were analyzed for ER stress-, barrier-, and mitochondrial-related markers. Tunicamycin-induced ER stress and polyinosinic-polycytidylic acid [Poly(I:C)]-stimulated inflammatory amplification models were established in 16HBE cells, followed by rescue treatment with 4-phenylbutyric acid (4-PBA) or MitoTEMPO. Results: Compared with healthy controls, RRTI children exhibited significantly increased HSPA5 and DDIT3 mRNA expression and elevated IL-6, IL-8, and CXCL10 protein levels (all P<0.001), whereas TJP1, OCLN, and TFAM expression was markedly reduced (all P<0.001). In 16HBE cells, tunicamycin induced ER stress activation, mitochondrial dysfunction, transepithelial electrical resistance (TEER) reduction, and epithelial permeability elevation. Under ER stress preconditioning, Poly(I:C)-induced inflammatory responses, mitochondrial reactive oxygen species (mtROS) accumulation, mitochondrial membrane potential collapse, and barrier leakage were further aggravated (all P<0.001). Both 4-PBA and MitoTEMPO partially reversed these pathological alterations. Conclusions: ER stress-mediated mitochondrial homeostasis disruption promotes airway epithelial barrier fragility and enhances inflammatory susceptibility in pediatric RRTIs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.